7/12/24 16:00 | 7/11/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | S | -2,032 | 1,089.0 | 0 | -2 | -5 | 38 | D | | | | | | | | | | | | | | |
6/25/24 16:39 | 6/24/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | M.d | 8,029 | 555.67 | 0 | 14 | 56 | 40 | D | | | | | | | | | | | | | | |
5/22/24 16:02 | 5/21/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | S | -1,855 | 994.90 | 0 | -2 | -5 | 38 | D | | | | | | | | | | | | | | |
2/28/24 16:04 | 2/26/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | S | -990 | 990.00 | 0 | -1 | -2 | 40 | D | | | | | | | | | | | | | | |
2/26/24 16:07 | 2/22/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | S | -968 | 967.65 | 0 | -1 | -2 | 41 | D | | | | | | | | | | | | | | |
2/9/24 16:12 | 2/7/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | S | -950 | 950.00 | 0 | -1 | -2 | 42 | D | | | | | | | | | | | | | | |
1/4/24 16:19 | 1/3/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | M.d | 13,588 | 399.66 | 0 | 34 | 367 | 43 | D | | | | | | | | | | | | | | |
3/27/23 16:39 | 3/23/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | M.d | 2,704 | 270.43 | 0 | 10 | 43 | 33 | D | | | | | | | | | | | | | | |
9/12/22 16:30 | 9/9/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Larosa Joseph J | NY | O | EVP GC,S | M.d | 8,113 | 270.43 | 0 | 30 | | 29 | D | | | | | | | | | | | | | | |